Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cytotherapy|September 24, 2019
More acute lymphoid leukemia than acute myeloid leukemia blasts are killed by rabbit antithymocyte globulinRosy Dabas, Poonam-Dharmani Khan, Monica Modi, et al.
The Oncologist|October 6, 2025
Management of Canadian patients with refractory or relapsed diffuse large B-cell lymphoma in the real world: a subanalysis of the RE-MIND2 studyAnthea Peters, Grzegorz S Nowakowski, Rosy Dabas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 21, 2018
Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the LevelsKareem Jamani, Rosy Dabas, Shahbal B Kangarloo, et al.
Bone Marrow Transplantation|August 16, 2018
Anti-thymocyte globulin's activity against acute myeloid leukemia stem cellsRosy Dabas, Poonam Dharmani-Khan, Monica Modi, et al.
Transplantation and Cellular Therapy|January 14, 2026
Population pharmacokinetics and optimal exposure of anti-thymocyte globulin in myeloablative hematopoietic cell transplantationHamid Ghazal, Sofia Leuchter, Riley Ngo, et al.
Transplantation and Cellular Therapy|October 4, 2021
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell TransplantationMegan Kinzel, Michelle Dowhan, Amit Kalra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2016
Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic BlastsRosy Dabas, Rachelle Lee, Maria Theresa Servito, et al.
Cytotherapy|January 1, 2020
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern eraChristopher Evernden, Michelle Dowhan, Rosy Dabas, et al.
Blood Advances|May 3, 2019
Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulinRosy Dabas, Kareem Jamani, Shahbal B Kangarloo, et al.
Cytotherapy|September 3, 2022
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host diseaseRutvij A Khanolkar, Gaurav Tripathi, Poonam Dharmani-Khan, et al.
Pageof 2